Clin2
NCT02357654Possibly a fitRecruiting

Hormone treatment to support the uterine lining in IVF cycles

Infertility

Part of Women’s health & pregnancy clinical trials.

This trial tests whether a hormone called GnRH can help support the lining of the uterus after IVF, ICSI, or frozen embryo (FET) embryo transfer. It may be offered around the time of embryo transfer to improve the chances of a successful implantation.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
350 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are a woman getting IVF, ICSI, or a frozen embryo transfer (FET)
  • You are under 40 years old
  • Your transfer is not a day 3 embryo transfer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06571214Not yet recruiting· Phase 4
Adding a hormone to IVF treatment for women aged 35 to 40

This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.

Nanjing, Jiangsu
NCT04719000Recruiting· Phase 4
Personalized LH addition during IVF to improve egg growth

This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.

Barcelona
NCT05899010Recruiting· Phase 3
Micronized progesterone for frozen embryo transfers

This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.

Barcelona
NCT07620067Recruiting
GnRH Hormone for IVF Embryo Support

This study tests whether a hormone called GnRH can improve success rates during IVF (in vitro fertilization) by supporting the embryo after transfer. If you're having IVF for the first to third time and your doctor is considering different support methods, this trial may explore options for you.

Jerusalem
NCT07653282Not yet recruiting· Phase 1/Phase 2
Hormone treatment to improve frozen embryo transfer success

This trial tests whether giving a medication called a GnRH agonist (which affects hormones) before a frozen embryo transfer can improve the chances of pregnancy in women with infertility. It aims to see if this treatment helps the uterus accept the embryo better.

Asyut, Muslum
NCT06150703Recruiting· Phase 3
Luteal phase support with GnRH agonist after egg retrieval trigger

This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.

Bondy

Hear when a new Infertility trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.